HomeInsightsPB

Orchid Pharma Ltd PB Ratio

Orchid Pharma Ltd PB Ratio

stocks purchased

₹ 0.1 Cr

Volume Transacted

(Nov 8, 2024)

stocks purchased

0.7 K

Stocks Traded

(Nov 8, 2024)

Last Updated on: Nov 08, 2024

Image

Orchid Pharma Ltd

NSE: ORCHPHARMA

PB

6.9

Last updated on: Nov 07, 2024

Key Highlights

  • The P/B Ratio of Orchid Pharma Ltd is 6.9 as of 07 Nov 24.
  • The P/B Ratio of Orchid Pharma Ltd changed from 2 on March 2022 to 4.8 on March 2024 . This represents a CAGR of 33.89% over 3 years. .

Historical P/B Ratio of Orchid Pharma Ltd

No data available

Company Fundamentals for Orchid Pharma Ltd

Market Cap

7,638 Cr

EPS

22.0

P/E Ratio (TTM) *

68.5

P/B Ratio (TTM) *

6.9

Day’s High *

1515.2

Day’s Low

1493.5

DTE *

0.1

ROE *

7.9

52 Week High

1591.55

52 Week Low

487.2

ROCE *

8.3

Market Price Over Time

1M

1Y

3Y

5Y

Monitoring Orchid Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
07 Nov 20241506
06 Nov 20241451.85
05 Nov 20241421.2
04 Nov 20241394.75
01 Nov 20241449.3
31 Oct 20241456.2
30 Oct 20241390.7
29 Oct 20241309.25
28 Oct 20241283.3
25 Oct 20241255.45

SWOT Analysis Of Orchid Pharma Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Orchid Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Orchid Pharma Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/B Ratio

Company NamePBMarket Cap (INR Cr.)
Orchid Pharma Ltd67,638
Sun Pharmaceuticals Industries Ltd994,29,841
Divis Laboratories Ltd5141,58,179
Cipla Ltd3621,27,063
Mankind Pharma Ltd2641,09,234
Dr Reddys Laboratories Ltd3181,07,398

Key Valuation Metric of Orchid Pharma Ltd

Share Price

₹1,499

PB Ratio

The price-to-book (P/B) ratio compares a company's market capitalization to its book value by dividing its stock price per share by its book value per share.


How to calculate Price-to-Book (P/B) Ratio?

The Price-to-Book Ratio is used to determine the relationship between the total value of a company's outstanding shares and the net value of its assets. Before calculating the P/B ratio, investors need to overlook the market capitalization of a company.


Market capitalization = market value of a stock X no. of outstanding shares


Now, you need to know the net value of an organization's assets.

Book Value of Assets = Total Assets - Total Liabilities of a company


After knowing the value of the above ratios, here is the formula for the P/B Ratio:

P/B Ratio = Market Capitalization/ Book Value of Assets


or you can also use this formula

P/B ratio = Market Price Per Share/ Book Value of Asset Per Share

Historical Market Cap of Orchid Pharma Ltd

No data available

* All values are in crore

Historical Revenue of Orchid Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Orchid Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Orchid Pharma Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Orchid Pharma Ltd News Hub

News

Orchid Pharma to hold board meeting

Orchid Pharma will hold a meeting of the Board of Directors of the Company on 11 November ...

Read more

06 Nov 202412:44

News

Orchid Pharma announces board meeting date

Orchid Pharma will hold a meeting of the Board of Directors of the Company on 12 August 20...

Read more

10 Aug 202412:49

News

Orchid Pharma to conduct AGM

Orchid Pharma announced that the Annual General Meeting (AGM) of the company will be held ...

Read more

18 Jul 202420:35

News

Orchid Pharma partners with Cipla for pan-India distribution of Cefepime-Enmetazobactam

Cefepime-Enmetazobactam has been approved for the treatment of complicated urinary tract i...

Read more

29 Jun 202410:08

News

Orchid Pharma partners with Cipla to launch antibiotic drug - Cefepime-Enmetazobactam in India

Orchid Pharma announced the launch of its new drug - Cefepime-Enmetazobactam, which has be...

Read more

28 Jun 202419:23

News

Orchid Pharma receives DCGI approval for Enmetazobactam

Orchid Pharma has received Drugs Controller General of India (DCGI) approval for the manuf...

Read more

06 Jun 202413:06

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PB Ratio of Orchid Pharma Ltd

What is the PB ratio of Orchid Pharma Ltd?

The current PB ratio of Orchid Pharma Ltd is 6.94. The Price-to-Book value (P/B) ratio compares a company's current share price to its book value per share. It helps assess whether a stock is overvalued or undervalued relative to its net asset value.

What is the ideal PB ratio to buy Orchid Pharma Ltd stocks?

An ideal PB ratio varies by industry; however, a PB ratio below 1.0 may indicate a good buying opportunity for Orchid Pharma Ltd. Some investors and financial analysts may also consider any value under 3.0 as a good PB ratio.

How is the PB Ratio of Orchid Pharma Ltd calculated?

The PB ratio of Orchid Pharma Ltd is calculated by dividing the current share price by the book value per share. The book value per share is determined by dividing the company’s total net assets (assets minus liabilities) by the number of outstanding shares. This ratio helps evaluate how the market values the company's assets.

What does a high PB Ratio mean for Orchid Pharma Ltd?

A high PB ratio suggests that Orchid Pharma Ltd’s stock may be overvalued relative to its book value or that investors expect high growth.

What does a low PB Ratio indicate for Orchid Pharma Ltd?

A low PB ratio of Orchid Pharma Ltd may indicate that the stock is undervalued or it is facing financial difficulties.

Can Orchid Pharma Ltd PB Ratio change over time?

Yes, the PB ratio of Orchid Pharma Ltd can change over time due to fluctuations in the company’s stock price and changes in its book value.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*